“Clinical trials in drug development” & Visit of Actelion clinical facilities

Clinical Trials Program

• 09.30 – 10.00 Welcome
• 10.00 – 10.45 LAURENT MONASSIER (Laboratory of Neurobiology & Cardiovascular Pharmacology EA 7296, Strasbourg) « FROM EXPERIMENTAL RESEARCH TO CLINICAL TRIALS: MILESTONES AND MAIN CAVEATS »
• 10.45 – 11.30 PHILIPPE WOLF (General Surgery & Transplantations, CHRU Strasbourg) « INFORMED CONSENT IN CLINICAL RESEARCH »
• 11.30 – 12.00 Coffee break
• 12.00 – 12.45 NICOLAS MEYER (Pole of Public Health, CHRU Strasbourg) « THE STATISTICAL AND METHODOLOGICAL DO’S AND DON’TS OF CLINICAL RESEARCH »
• 12.45 – 13.15 LAURENT MONASSIER, PHILIPPE WOLF & NICOLAS MEYER « CLINICAL DESIGN FOR CLINICAL TRIALS IN NEUROLOGY : PRACTICAL EXAMPLES »
• 13.15 – 14.30 Lunch break

Visit of actelion clinical facilities

Allschwil, Basel – (Auditorium, H91)

• 15.00 – 15.05 ANGELIKA ROSE-HÜLL (Consultant Visitors & Science Education) > WELCOME
• 15.05 – 15.30 RAVI SODHA (Senior Director Business Development) > COMPANY PRESENTATION
• 15.30 – 16.15 JASPER DINGEMANSE (Head Clinical Pharmacology) > USE OF BIOMARKERS IN THE EARLY DEVELOPMENT OF A NEW HYPNOTIC WITH A NEW MECHANISM OF ACTION
• 16.20 – 16.50 FRANCESCA MASSA-ROLANDINO (Head Clinical Development Data Management) > OPENING THE DOORS TO THE WORLD OF DATA MANAGEMENT @ ACTELION
• 16.50 – 17.00 Break
• 17.00 – 17.30 CECILE VALETTE (Head of Medical Safety Surveillance) > PHARMACOVIGILANCE IN ACTELION